These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 11910596

  • 1. Increased reduction in bone density and skin thickness in postmenopausal women taking long-term corticosteroid therapy: a suggested role for estrogen add-back therapy.
    Baron YM, Brincat MP, Galea R.
    Climacteric; 1999 Sep; 2(3):189-96. PubMed ID: 11910596
    [Abstract] [Full Text] [Related]

  • 2. Increased reduction in bone density and skin thickness in postmenopausal women on long-term corticosteroid therapy. A suggested role for estrogen add back therapy.
    Baron YM, Brincat M, Galea R.
    Adv Exp Med Biol; 1999 Sep; 455():429-36. PubMed ID: 10599380
    [Abstract] [Full Text] [Related]

  • 3. Corticosteroid effects on proximal femur bone loss.
    Sambrook P, Birmingham J, Kempler S, Kelly P, Eberl S, Pocock N, Yeates M, Eisman J.
    J Bone Miner Res; 1990 Dec; 5(12):1211-6. PubMed ID: 2075834
    [Abstract] [Full Text] [Related]

  • 4. The benefit of hormone replacement therapy on bone mass is greater at the vertebral body than posterior processes or proximal femur.
    Duan Y, Tabensky A, DeLuca V, Seeman E.
    Bone; 1997 Nov; 21(5):447-51. PubMed ID: 9356739
    [Abstract] [Full Text] [Related]

  • 5. Differential effects of estrogen treatment on bone mineral density of the spine, hip, wrist and total body in late postmenopausal women.
    Kohrt WM, Birge SJ.
    Osteoporos Int; 1995 May; 5(3):150-5. PubMed ID: 7655174
    [Abstract] [Full Text] [Related]

  • 6. Parathyroid hormone treatment can reverse corticosteroid-induced osteoporosis. Results of a randomized controlled clinical trial.
    Lane NE, Sanchez S, Modin GW, Genant HK, Pierini E, Arnaud CD.
    J Clin Invest; 1998 Oct 15; 102(8):1627-33. PubMed ID: 9788977
    [Abstract] [Full Text] [Related]

  • 7. Differential effects of hormone replacement therapy on bone mineral density and axial transmission ultrasound measurements in cortical bone.
    Knapp KM, Blake GM, Spector TD, Fogelman I.
    Osteoporos Int; 2003 Jun 15; 14(4):289-94. PubMed ID: 12730793
    [Abstract] [Full Text] [Related]

  • 8. Bone health in urban midlife Malaysian women: risk factors and prevention.
    Lim PS, Ong FB, Adeeb N, Seri SS, Noor-Aini MY, Shamsuddin K, Hapizah N, Mohamed AL, Mokhtar A, Wan HW.
    Osteoporos Int; 2005 Dec 15; 16(12):2069-79. PubMed ID: 16234999
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Does vitamin D strengthen the increase in femoral neck BMD in osteoporotic women treated with estrogen?
    Tuppurainen MT, Komulainen M, Kröger H, Honkanen R, Jurvelin J, Puntila E, Heikkinen AM, Alhava E, Saarikoski S.
    Osteoporos Int; 1998 Dec 15; 8(1):32-8. PubMed ID: 9692075
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Prospective 10-year study of the determinants of bone density and bone loss in normal postmenopausal women, including the effect of hormone replacement therapy.
    Wu F, Ames R, Clearwater J, Evans MC, Gamble G, Reid IR.
    Clin Endocrinol (Oxf); 2002 Jun 15; 56(6):703-11. PubMed ID: 12072039
    [Abstract] [Full Text] [Related]

  • 13. Quantitative computed tomography of the lumbar spine, not dual x-ray absorptiometry, is an independent predictor of prevalent vertebral fractures in postmenopausal women with osteopenia receiving long-term glucocorticoid and hormone-replacement therapy.
    Rehman Q, Lang T, Modin G, Lane NE.
    Arthritis Rheum; 2002 May 15; 46(5):1292-7. PubMed ID: 12115236
    [Abstract] [Full Text] [Related]

  • 14. [Effects of estrogen therapy on bone mass in postmenopausal women with osteopenia].
    Insua A, Negri A, Zanchetta JR.
    Medicina (B Aires); 1995 May 15; 55(5 Pt 1):408-14. PubMed ID: 8728770
    [Abstract] [Full Text] [Related]

  • 15. Long-term postmenopausal hormone replacement therapy effects on bone mass: differences between surgical and spontaneous patients.
    Castelo-Branco C, Figueras F, Sanjuan A, Pons F, Vicente JJ, Vanrell JA.
    Eur J Obstet Gynecol Reprod Biol; 1999 Apr 15; 83(2):207-11. PubMed ID: 10391534
    [Abstract] [Full Text] [Related]

  • 16. Two to three years of hormone replacement treatment in healthy women have long-term preventive effects on bone mass and osteoporotic fractures: the PERF study.
    Bagger YZ, Tankó LB, Alexandersen P, Hansen HB, Møllgaard A, Ravn P, Qvist P, Kanis JA, Christiansen C.
    Bone; 2004 Apr 15; 34(4):728-35. PubMed ID: 15050905
    [Abstract] [Full Text] [Related]

  • 17. Effects on bone mass after eight years of hormonal replacement therapy.
    Eiken P, Nielsen SP, Kolthoff N.
    Br J Obstet Gynaecol; 1997 Jun 15; 104(6):702-7. PubMed ID: 9197874
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effect of parity on bone mineral density among postmenopausal Saudi Arabian women.
    Sadat-Ali M, Al-Habdan I, Al-Mulhim AA, El-Hassan AY.
    Saudi Med J; 2005 Oct 15; 26(10):1588-90. PubMed ID: 16228061
    [Abstract] [Full Text] [Related]

  • 20. Prevalence of low bone mass in postmenopausal Kuwaiti women residents in the largest province of Kuwait.
    Al-Shoumer KA, Nair V.
    Arch Osteoporos; 2012 Oct 15; 7():147-53. PubMed ID: 23225292
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.